Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.verified

LSTA

Price:

$5.03

Market Cap:

$45.43M

Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerl...[Read more]

Industry

Biotechnology

IPO Date

1999-03-01

Stock Exchange

NASDAQ

Ticker

LSTA

The Enterprise Value as of March 2026 (TTM) for Lisata Therapeutics, Inc. (LSTA) is 29.48M

According to Lisata Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 29.48M. This represents a change of 854.43% compared to the average of 3.09M of the last 4 quarters.

Lisata Therapeutics, Inc. (LSTA) Historical Enterprise Value (quarterly & annually)

How has LSTA Enterprise Value performed in the past?

The mean historical Enterprise Value of Lisata Therapeutics, Inc. over the last ten years is 7.26M. The current 29.48M Enterprise Value has changed 40.52% with respect to the historical average. Over the past ten years (40 quarters), LSTA's Enterprise Value was at its highest in in the June 2021 quarter at 83.31M. The Enterprise Value was at its lowest in in the December 2022 quarter at -19111345.00.

Quarterly (TTM)
Annual

Average

7.26M

Median

7.47M

Minimum

-18563600.00

Maximum

24.19M

Lisata Therapeutics, Inc. (LSTA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lisata Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 291.76%

Maximum Annual Enterprise Value = 24.19M

Minimum Annual Increase = -2368.13%

Minimum Annual Enterprise Value = -18563600.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025201.82K-97.69%
20248.75M-2368.13%
2023-385710.00-97.92%
2022-18563600.00-182.37%
202122.54M264.42%
20206.18M-51.92%
201912.86M-46.84%
201824.19M291.76%
20176.18M-41.84%
201610.62M-78.26%

Lisata Therapeutics, Inc. (LSTA) Average Enterprise Value

How has LSTA Enterprise Value performed in the past?

The current Enterprise Value of Lisata Therapeutics, Inc. (LSTA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

2.85M

5-year avg

2.51M

10-year avg

7.26M

Lisata Therapeutics, Inc. (LSTA) Enterprise Value vs. Peers

How is LSTA’s Enterprise Value compared to its peers?

Lisata Therapeutics, Inc.’s Enterprise Value is greater than MetaVia Inc. (-10653669.00), greater than NuCana plc (-16373341.56), greater than Enlivex Therapeutics Ltd. (21.78M), greater than Passage Bio, Inc. (1.61M), greater than Exicure, Inc. (22.70M), greater than CASI Pharmaceuticals, Inc. (16.32M), less than Clearside Biomedical, Inc. (57.69M), greater than Pelthos Therapeutics Inc. (5.12M), greater than Klotho Neurosciences, Inc. (20.28M), greater than CollPlant Biotechnologies Ltd. (1.88M),

Build a custom stock screener for Lisata Therapeutics, Inc. (LSTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lisata Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lisata Therapeutics, Inc. (LSTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lisata Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Lisata Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Lisata Therapeutics, Inc. (LSTA)?

What is the 3-year average Enterprise Value for Lisata Therapeutics, Inc. (LSTA)?

What is the 5-year average Enterprise Value for Lisata Therapeutics, Inc. (LSTA)?

How does the current Enterprise Value for Lisata Therapeutics, Inc. (LSTA) compare to its historical average?